Medpace Holdings, Inc.
NASDAQ:MEDP
342.89 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Medpace Holdings, Inc. |
Symbool | MEDP |
Munteenheid | USD |
Prijs | 342.89 |
Beurswaarde | 10,630,207,202 |
Dividendpercentage | 0% |
52-weken bereik | 227.21 - 459.77 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. August James Troendle M.D. |
Website | https://www.medpace.com |
An error occurred while fetching data.
Over Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)